Pembrolizumab and GM-CSF in Biliary Cancer
Clinical trial NCT02703714 · COMPLETED
Trial details
- NCT number
- NCT02703714
- Sponsor
- Robin Kate Kelley
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-06
- Primary completion
- 2020-12-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.